Cronos Group Inc. (CRON)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Cronos Group Inc. (CRON) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $1.14B, a trailing price-to-earnings ratio of 22.1 and a free-cash-flow yield of -0.0%. Over the most recent reported fiscal year, revenue grew 24.6% and free cash flow per share fell 103.4%.

Market cap	$1.14B
Trailing P/E	22.1
FCF yield	-0.0%
Revenue growth (YoY)	+24.6%
EPS growth (YoY)	—
FCF/share growth (YoY)	-103.4%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live CRON data on Nama Insights →

Recent Congressional trades

Cronos Group Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
John A. Yarmuth	House	Buy	$1,001 - $15,000	Feb 19, 2021
John A. Yarmuth	House	Buy	$1,001 - $15,000	Nov 10, 2020